| Application no. and date | 18713735.1 (espacenet) (Federated) (European Patent Register), 20180116 | | Patent/reg. no. and date | DK/EP 3570884, 20200930 | | Publication date | 20191127 | | Priority no. and date | US 201762447359 P, 20170117 | | EP pub. no. and date |
EP 3570884 20191127 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH,
Genentech, Inc., 1 DNA Way
South San Francisco,
CA 94080, US | | Applicant ref. no. | P74921DK01 | | Inventor | ALAVATTAM, Sreedhara, c/o Genentech Inc.
1 Dna Way
South San Francisco, CA 94080, US,
KHAN, Tarik, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
HEESON, Sarah, c/o Roche Products Limited
Hexagon Place
6 Falcon Way
Shire Park
Welwyn Garden City
Greater London AL7 1TW, GB,
BADOVINAC-CRNJEVIC, Tanja, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
WURTH, Christine, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
ENG-WONG, Jennifer, c/o Genentech Inc.
1 DNA Way
South San Francisco,CA 94080, US,
KIRSCHBROWN, Whitney, c/o Genentech Inc.
1 DNA Way
South San Francisco,CA 94080, US,
LIN, Jasper, c/o Genentech Inc.
1 DNA Way
South San Francisco,CA 94080, US,
GARG, Amit, c/o Genentech Inc.
1 DNA Way
South San Francisco,CA 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/47 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 47/42 (2017.01) , A61K 9/08 (2006.01) , A61P 35/00 (2006.01) , C07K 16/32 (2006.01) | | Title | Subkutane HER2-antistofformuleringer | | Int. application no. | US2018013854 | | Int. publication no. | WO2018136412 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
